Victor R. L. J. Bloemendal
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Victor R. L. J. Bloemendal has a total of 28 co-authors. Here are the top co-authors by number of shared publications:
- Floris P. J. T. Rutjes
Institute for Molecules and Materials, Radboud University, Heyendaalseweg 135, 6525 AJ Nijmegen, The Netherlands
5 shared publications - Jan C. M. van Hest
Bio-Organic Chemistry, Department of Biomedical Engineering, Institute for Complex Molecular Systems (ICMS), Eindhoven University of Technology, Eindhoven, The Netherlands
4 shared publications - Thomas Jan Boltje
Institute for Molecules and Materials Radboud University Nijmegen The Netherlands
3 shared publications - Christian BĂŒll
Department of Biomolecular Chemistry, Institute for Molecules and Materials, Radboud University , Heyendaalseweg 135, 6525 AJ, Nijmegen
2 shared publications - Gosse J. Adema
Radboud University Medical Center 1 Radiotherapy and OncoImmunology Laboratory, Department of Radiation Oncology Nijmegen, the Netherlands
2 shared publications Martijn H. Den Brok
Radiotherapy & OncoImmunology Laboratory, Department of Radiation Oncology, Radboud Institute for Molecular Life Sciences, Radboud University Medical Center, Nijmegen, The Netherlands
2 shared publications
Latest Publications
- Open Access
- 4 January 2021
- Published by Springer Nature in Journal of Flow Chemistry
- Vol. 11  (2) , 99-105
One-flow synthesis of tetrahydrocannabinol and cannabidiol using homo- and heterogeneous Lewis acids
Continuous flow chemistry holds great potential for the production of biologically relevant molecules. Herein, we present an approach for the continuous synthesis of cannabidiol and tetrahydrocannabinol in a one-flow system. The designed route consists of a reaction cascade involving Friedel-Crafts alkylation, subsequent ring opening and cyclisation in up to 45% yield. The reactions were successfully performed using both hetero- and homogeneous Lewis acids in continuous flow and provide yields that are similar to comparable batch processes.Graphical abstract
- 4 January 2021
- Published by Springer Nature in Journal of Flow Chemistry
- Vol. 11  (2) , 99-105
Open AccessOne-flow synthesis of tetrahydrocannabinol and cannabidiol using homo- and heterogeneous Lewis acids
Continuous flow chemistry holds great potential for the production of biologically relevant molecules. Herein, we present an approach for the continuous synthesis of cannabidiol and tetrahydrocannabinol in a one-flow system. The designed route consists of a reaction cascade involving Friedel-Crafts alkylation, subsequent ring opening and cyclisation in up to 45% yield. The reactions were successfully performed using both hetero- and homogeneous Lewis acids in continuous flow and provide yields that are similar to comparable batch processes.Graphical abstract
- Open Access
- 26 May 2020
- Published by Royal Society of Chemistry (RSC) in Reaction Chemistry & Engineering
- Vol. 5  (7) , 1186-1197
Continuous one-flow multi-step synthesis of active pharmaceutical ingredients
This review highlights a selection of multistep continuous flow (one-flow) processes leading to the synthesis of active pharmaceutical ingredients (APIs).
- 26 May 2020
- Published by Royal Society of Chemistry (RSC) in Reaction Chemistry & Engineering
- Vol. 5  (7) , 1186-1197
Open AccessContinuous one-flow multi-step synthesis of active pharmaceutical ingredients
This review highlights a selection of multistep continuous flow (one-flow) processes leading to the synthesis of active pharmaceutical ingredients (APIs).
- Open Access
- 31 March 2020
- Published by Royal Society of Chemistry (RSC) in Organic & Biomolecular Chemistry
- Vol. 18  (17) , 3203-3215
Synthetic pathways to tetrahydrocannabinol (THC): an overview
This review summarises various synthetic pathways leading to tetrahydrocannabinol and structurally related cannabinoids.
- 31 March 2020
- Published by Royal Society of Chemistry (RSC) in Organic & Biomolecular Chemistry
- Vol. 18  (17) , 3203-3215
Open AccessSynthetic pathways to tetrahydrocannabinol (THC): an overview
This review summarises various synthetic pathways leading to tetrahydrocannabinol and structurally related cannabinoids.
- Open Access
- 4 April 2019
- Published by Wiley in Advanced Synthesis & Catalysis
- Vol. 361  (11) , 2443-2447
Chemoenzymatic Synthesis of Sialic Acid Derivatives Using Immobilized NâAcetylneuraminate Lyase in a Continuous Flow Reactor
The synthesis of Nâacetylneuraminic acid (Neu5Ac) derivatives is drawing more and more attention in glycobiology research because of the important role of sialic acids in e. g. cancer, bacterial, and healthy cells. Chemical preparation of these carbohydrates typically relies on multistep synthetic procedures leading to low overall yields. Herein we report a continuous flow process involving Nâacetylneuraminate lyase (NAL) immobilized on Immobead 150P (ImmobeadâNAL) to prepare Neu5Ac derivatives. Batch experiments with ImmobeadâNAL showed equal activity as the native enzyme. Moreover, by using a fivefold excess of either NâacetylâDâmannosamine (ManNAc) or pyruvate the conversion and isolated yield of Neu5Ac were significantly improved. To further increase the efficiency of the process, a flow setup was designed providing a chemoenzymatic entry into a series of Nâfunctionalized Neu5Ac derivatives in conversions of 48â82%, and showing excellent stability over 1 week of continuous use. magnified image
- 4 April 2019
- Published by Wiley in Advanced Synthesis & Catalysis
- Vol. 361  (11) , 2443-2447
Open AccessChemoenzymatic Synthesis of Sialic Acid Derivatives Using Immobilized NâAcetylneuraminate Lyase in a Continuous Flow Reactor
The synthesis of Nâacetylneuraminic acid (Neu5Ac) derivatives is drawing more and more attention in glycobiology research because of the important role of sialic acids in e. g. cancer, bacterial, and healthy cells. Chemical preparation of these carbohydrates typically relies on multistep synthetic procedures leading to low overall yields. Herein we report a continuous flow process involving Nâacetylneuraminate lyase (NAL) immobilized on Immobead 150P (ImmobeadâNAL) to prepare Neu5Ac derivatives. Batch experiments with ImmobeadâNAL showed equal activity as the native enzyme. Moreover, by using a fivefold excess of either NâacetylâDâmannosamine (ManNAc) or pyruvate the conversion and isolated yield of Neu5Ac were significantly improved. To further increase the efficiency of the process, a flow setup was designed providing a chemoenzymatic entry into a series of Nâfunctionalized Neu5Ac derivatives in conversions of 48â82%, and showing excellent stability over 1 week of continuous use. magnified image
- Open Access
- 3 March 2019
- Published by Wiley in European Journal of Organic Chemistry
- Vol. 2019  (12) , 2289-2296
A Revised Modular Approach to (â)âtransâÎ8âTHC and Derivatives Through LateâStage SuzukiâMiyaura CrossâCoupling Reactions
A revised modular approach to various synthetic (â)âtransâÎ8âTHC derivatives through lateâstage SuzukiâMiyaura crossâcoupling reactions is disclosed. Ten derivatives were synthesized allowing both sp2â and sp3âhybridized crossâcoupling partners with minimal ÎČâhydride elimination. Importantly, we demonstrate that a paraâbromoâsubstituted THC scaffold for SuzukiâMiyaura crossâcoupling reactions has been initially reported incorrectly in recent literature.
- 3 March 2019
- Published by Wiley in European Journal of Organic Chemistry
- Vol. 2019  (12) , 2289-2296
Open AccessA Revised Modular Approach to (â)âtransâÎ8âTHC and Derivatives Through LateâStage SuzukiâMiyaura CrossâCoupling Reactions
A revised modular approach to various synthetic (â)âtransâÎ8âTHC derivatives through lateâstage SuzukiâMiyaura crossâcoupling reactions is disclosed. Ten derivatives were synthesized allowing both sp2â and sp3âhybridized crossâcoupling partners with minimal ÎČâhydride elimination. Importantly, we demonstrate that a paraâbromoâsubstituted THC scaffold for SuzukiâMiyaura crossâcoupling reactions has been initially reported incorrectly in recent literature.
- Top Cited Papers
- 1 July 2018
- Published by American Association for Cancer Research (AACR) in Cancer Research
- Vol. 78  (13) , 3574-3588
Sialic Acid Blockade Suppresses Tumor Growth by Enhancing T-cellâMediated Tumor Immunity
Sialic acid sugars on the surface of cancer cells have emerged as potent immune modulators that contribute to the immunosuppressive microenvironment and tumor immune evasion. However, the mechanisms by which these sugars modulate antitumor immunity as well as therapeutic strategies directed against them are limited. Here we report that intratumoral injections with a sialic acid mimetic Ac53FaxNeu5Ac block tumor sialic acid expression in vivo and suppress tumor growth in multiple tumor models. Sialic acid blockade had a major impact on the immune cell composition of the tumor, enhancing tumor-infiltrating natural killer cell and CD8+ T-cell numbers while reducing regulatory T-cell and myeloid regulatory cell numbers. Sialic acid blockade enhanced cytotoxic CD8+ T-cellâmediated killing of tumor cells in part by facilitating antigen-specific T-cellâtumor cell clustering. Sialic acid blockade also synergized with adoptive transfer of tumor-specific CD8+ T cells in vivo and enhanced CpG immune adjuvant therapy by increasing dendritic cell activation and subsequent CD8+ T-cell responses. Collectively, these data emphasize the crucial role of sialic acids in tumor immune evasion and provide proof of concept that sialic acid blockade creates an immune-permissive tumor microenvironment for CD8+ T-cellâmediated tumor immunity, either as single treatment or in combination with other immune-based intervention strategies. Significance: Sialic acid sugars function as important modulators of the immunosuppressive tumor microenvironment that limit potent antitumor immunity. Graphical http://cancerres.aacrjournals.org/content/canres/78/13/3574/F1.large.jpg. Cancer Res; 78(13); 3574â88. ©2018 AACR.
- 1 July 2018
- Published by American Association for Cancer Research (AACR) in Cancer Research
- Vol. 78  (13) , 3574-3588
Top Cited PapersSialic Acid Blockade Suppresses Tumor Growth by Enhancing T-cellâMediated Tumor Immunity
Sialic acid sugars on the surface of cancer cells have emerged as potent immune modulators that contribute to the immunosuppressive microenvironment and tumor immune evasion. However, the mechanisms by which these sugars modulate antitumor immunity as well as therapeutic strategies directed against them are limited. Here we report that intratumoral injections with a sialic acid mimetic Ac53FaxNeu5Ac block tumor sialic acid expression in vivo and suppress tumor growth in multiple tumor models. Sialic acid blockade had a major impact on the immune cell composition of the tumor, enhancing tumor-infiltrating natural killer cell and CD8+ T-cell numbers while reducing regulatory T-cell and myeloid regulatory cell numbers. Sialic acid blockade enhanced cytotoxic CD8+ T-cellâmediated killing of tumor cells in part by facilitating antigen-specific T-cellâtumor cell clustering. Sialic acid blockade also synergized with adoptive transfer of tumor-specific CD8+ T cells in vivo and enhanced CpG immune adjuvant therapy by increasing dendritic cell activation and subsequent CD8+ T-cell responses. Collectively, these data emphasize the crucial role of sialic acids in tumor immune evasion and provide proof of concept that sialic acid blockade creates an immune-permissive tumor microenvironment for CD8+ T-cellâmediated tumor immunity, either as single treatment or in combination with other immune-based intervention strategies. Significance: Sialic acid sugars function as important modulators of the immunosuppressive tumor microenvironment that limit potent antitumor immunity. Graphical http://cancerres.aacrjournals.org/content/canres/78/13/3574/F1.large.jpg. Cancer Res; 78(13); 3574â88. ©2018 AACR.
- 14 February 2017
- Published by Wiley in Angewandte Chemie International Edition
- Vol. 56  (12) , 3309-3313
Steering SiglecâSialic Acid Interactions on Living Cells using Bioorthogonal Chemistry
Sialic acid sugars that terminate cellâsurface glycans form the ligands for the sialic acid binding immunoglobulinâlike lectin (Siglec) family, which are immunomodulatory receptors expressed by immune cells. Interactions between sialic acid and Siglecs regulate the immune system, and aberrations contribute to pathologies like autoimmunity and cancer. Sialic acid/Siglec interactions between living cells are difficult to study owing to a lack of specific tools. Here, we report a glycoengineering approach to remodel the sialic acids of living cells and their binding to Siglecs. Using bioorthogonal chemistry, a library of cells with more than sixty different sialic acid modifications was generated that showed dramatically increased binding toward the different Siglec family members. Rational design reduced crossâreactivity and led to the discovery of three selective Siglecâ5/14 ligands. Furthermore, glycoengineered cells carrying sialic acid ligands for Siglecâ3 dampened the activation of Siglecâ3+ monocytic cells through the NFâÎșB and IRF pathways.
- 14 February 2017
- Published by Wiley in Angewandte Chemie International Edition
- Vol. 56  (12) , 3309-3313
Steering SiglecâSialic Acid Interactions on Living Cells using Bioorthogonal Chemistry
Sialic acid sugars that terminate cellâsurface glycans form the ligands for the sialic acid binding immunoglobulinâlike lectin (Siglec) family, which are immunomodulatory receptors expressed by immune cells. Interactions between sialic acid and Siglecs regulate the immune system, and aberrations contribute to pathologies like autoimmunity and cancer. Sialic acid/Siglec interactions between living cells are difficult to study owing to a lack of specific tools. Here, we report a glycoengineering approach to remodel the sialic acids of living cells and their binding to Siglecs. Using bioorthogonal chemistry, a library of cells with more than sixty different sialic acid modifications was generated that showed dramatically increased binding toward the different Siglec family members. Rational design reduced crossâreactivity and led to the discovery of three selective Siglecâ5/14 ligands. Furthermore, glycoengineered cells carrying sialic acid ligands for Siglecâ3 dampened the activation of Siglecâ3+ monocytic cells through the NFâÎșB and IRF pathways.